| Natural products from myxobacteria: novel metabolites and bioactivities J Herrmann, A Abou Fayad, R Müller Natural product reports 34 (2), 135-160, 2017 | 271 | 2017 |
| Heavy Metal Toxicity in Armed Conflicts Potentiates AMR in A. baumannii by Selecting for Antibiotic and Heavy Metal Co-resistance Mechanisms W Bazzi, AG Abou Fayad, A Nasser, LP Haraoui, O Dewachi, ... Frontiers in microbiology 11, 68, 2020 | 134 | 2020 |
| The generation of “unnatural” products: synthetic biology meets synthetic chemistry RJM Goss, S Shankar, A Abou Fayad Natural Product Reports 29 (8), 870-889, 2012 | 119 | 2012 |
| Genome-wide mutant profiling predicts the mechanism of a Lipid II binding antibiotic M Santiago, W Lee, AA Fayad, KA Coe, M Rajagopal, T Do, F Hennessen, ... Nature chemical biology 14 (6), 601-608, 2018 | 68 | 2018 |
| Sonogashira diversification of unprotected halotryptophans, halotryptophan containing tripeptides; and generation of a new to nature bromo-natural product and its … MJ Corr, SV Sharma, C Pubill-Ulldemolins, RT Bown, P Poirot, ... Chemical Science 8 (3), 2039-2046, 2017 | 48 | 2017 |
| Structure and Biosynthesis of Crocagins: Polycyclic Posttranslationally Modified Ribosomal Peptides from Chondromyces crocatus K Viehrig, F Surup, C Volz, J Herrmann, A Abou Fayad, S Adam, J Köhnke, ... Angewandte Chemie International Edition 56 (26), 7407-7410, 2017 | 45 | 2017 |
| Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean Region over the last decade A Sleiman, AG Abou Fayad, H Banna, GM Matar Journal of Global Antimicrobial Resistance 25, 209-221, 2021 | 35 | 2021 |
| Engineering Atypical Tetracycline Formation in Amycolatopsis sulphurea for the Production of Modified Chelocardin Antibiotics T Lukežič, AA Fayad, C Bader, K Harmrolfs, J Bartuli, S Groß, ... ACS chemical biology 14 (3), 468-477, 2019 | 33 | 2019 |
| Antimicrobial resistance and the Iraq wars: armed conflict as an underinvestigated pathway with growing significance A Abou Fayad, A Rizk, S El Sayed, M Kaddoura, NK Jawad, A Al-Attar, ... BMJ Global Health 7 (Suppl 8), e010863, 2023 | 28 | 2023 |
| An unequivocal superbug: PDR Klebsiella pneumoniae with an arsenal of resistance and virulence factor genes A Sleiman, B Awada, M Mocadie, N Sherri, LP Haraoui, V Baby, GF Araj, ... The Journal of Infection in Developing Countries 15 (03), 404-414, 2021 | 28 | 2021 |
| Total biosynthesis of the pyrrolo [4, 2] benzodiazepine scaffold tomaymycin on an in vitro reconstituted NRPS system A von Tesmar, M Hoffmann, J Pippel, A Abou Fayad, S Dausend-Werner, ... Cell chemical biology 24 (10), 1216-1227. e8, 2017 | 26 | 2017 |
| Biosynthesis of the Klebsiella oxytoca Pathogenicity Factor Tilivalline: Heterologous Expression, in Vitro Biosynthesis, and Inhibitor Development A von Tesmar, M Hoffmann, A Abou Fayad, S Hüttel, V Schmitt, ... ACS chemical biology 13 (3), 812-819, 2018 | 25 | 2018 |
| Antimicrobial resistance in the ongoing Gaza war: a silent threat K Moussally, G Abu-Sittah, FG Gomez, A Abou Fayad, A Farra The Lancet 402 (10416), 1972-1973, 2023 | 23 | 2023 |
| Phenotypic and Genotypic Characterization of Extended‐Spectrum Beta‐Lactamases Produced by Escherichia coli Colonizing Pregnant Women N Ghaddar, E Anastasiadis, R Halimeh, A Ghaddar, GM Matar, ... Infectious diseases in obstetrics and gynecology 2020 (1), 4190306, 2020 | 21 | 2020 |
| Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo B El Hafi, SS Rasheed, AG Abou Fayad, GF Araj, GM Matar Frontiers in Microbiology 10, 933, 2019 | 17 | 2019 |
| Drosophila melanogaster as a Model System to Assess the Effect of Epstein-Barr Virus DNA on Inflammatory Gut Diseases JR Madi, AA Outa, M Ghannam, HM Hussein, M Shehab, ZAKH Hasan, ... Frontiers in immunology 12, 586930, 2021 | 15 | 2021 |
| Natural products and polysorbates: Potential Inhibitors of biofilm formation in Pseudomonas aeruginosa M Miari, SS Rasheed, NH Ahmad, D Itani, A Abou Fayad, GM Matar The Journal of Infection in Developing Countries 14 (06), 580-588, 2020 | 15 | 2020 |
| Octapeptins: lipopeptide antibiotics against multidrug-resistant superbugs A Abou Fayad, J Herrmann, R Müller Cell chemical biology 25 (4), 351-353, 2018 | 13 | 2018 |
| An unusual two-strain cholera outbreak in Lebanon, 2022-2023: a genomic epidemiology study A Abou Fayad, R Rafei, E Njamkepo, J Ezzeddine, H Hussein, S Sinno, ... Nature Communications 15 (1), 6963, 2024 | 10 | 2024 |
| Clinical predictors of mortality in patients with pseudomonas aeruginosa infection JA Frem, G Doumat, J Kazma, A Gharamti, SS Kanj, AG Abou Fayad, ... PLoS One 18 (4), e0282276, 2023 | 10 | 2023 |
Ghassan MatarAmerican University of BeirutZweryfikowany adres z aub.edu.lb
